Equities
  • Price (EUR)39.37
  • Today's Change0.515 / 1.33%
  • Shares traded0.00
  • 1 Year change+26.54%
  • Beta1.0936
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

DuPont de Nemours, Inc. is engaged in providing advanced solutions that help transform industries. The Company serves various markets, including healthcare, water, construction, and transportation. The Company’s IndustrialsCo segment is a provider of engineered products and integrated solutions primarily serving medical, including packaging and specialty medical devices, water filtration, worker safety, automotive, including electric vehicles, aerospace and building product end markets. The IndustrialsCo segment offers medical packaging, medical silicones, specialty medical devices, water purification and separation, water filtration and purification resins, flexible packaging products, nonwovens, aramids, construction materials, auto adhesives and fluids.

  • Revenue in USD (TTM)12.49bn
  • Net income in USD-109.00m
  • Incorporated2015
  • Employees24.00k
  • Location
    Dupont De Nemours Inc974 Centre Rd Bldg 730WILMINGTON 19805United StatesUSA
  • Phone+1 (302) 658-7581
  • Fax+1 (302) 655-5049
  • Websitehttps://www.dupont.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
DD:NYQ since
announced
Transaction
value
Dupont Teijin Advanced PaperAnnounced29 Aug 202529 Aug 2025Announced43.92%--
DuPont Teijin Advanced Papers (Asia) LtdAnnounced29 Aug 202529 Aug 2025Announced43.92%--
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.